Upregulated β-MHC and decreased SERCA2 levels have been associated with diastolic dysfunction, but preserved systolic function in diabetic cardiomyopathy [45], suggesting that cardiac contractile dysfunction results from the combined effects of altered Ca2+ handling and altered MHC expression. This evidence concerns the gene ATP2A2 and diabetic cardiomyopathy.